Related Experiment Video
Updated: Jul 5, 2026

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
SENTINOLD and the Challenge of Meaningful Risk Prediction in Melanoma
1Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
International Journal of Dermatology
|July 4, 2026
Abstract
No abstract available in PubMed .